Point72 Asset Management, L.P. - Q4 2013 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q4 2013
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TR38Q3 20238.2%
CME GROUP INC38Q3 20230.3%
BUNGE LIMITED37Q2 20231.5%
AMAZON COM INC36Q3 20233.2%
META PLATFORMS INC36Q3 20232.2%
VISA INC35Q3 20231.6%
AIR PRODS & CHEMS INC35Q3 20230.7%
BERRY PLASTICS GROUP INC35Q3 20230.8%
XENON PHARMACEUTICALS INC35Q3 20230.4%
CSX CORP34Q3 20231.3%

View Point72 Asset Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
Point72 Asset Management, L.P. Q4 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Turnstone Biologics Corp.July 27, 2023833,3333.8%
Praxis Precision Medicines, Inc.June 26, 202310,438,5228.1%
Cepton, Inc.March 09, 20231,813,5351.2%
Achilles Therapeutics plcFebruary 14, 20231,413,8093.6%
Affimed N.V.February 14, 20234,207,2202.8%
Akero Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Applied Therapeutics Inc.February 14, 2023719,9383.2%
Atara Biotherapeutics, Inc.Sold outFebruary 14, 202300.0%
Avalo Therapeutics, Inc.February 14, 2023500,7375.3%
Axogen, Inc.February 14, 20231,815,0004.3%

View Point72 Asset Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G2024-05-09
SC 13G2024-04-26
SC 13G2024-04-05
SC 13G2024-03-26
SC 13G2024-03-25
SC 13G2024-03-07
SC 13G2024-02-29
SC 13G2024-02-27
SC 13G2024-02-23

View Point72 Asset Management, L.P.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Export Point72 Asset Management, L.P.'s holdings

CSVXLS